Delivery Order SPE2DB24D3013-SPE2DB26FFGHZ
- Not listed
- The Defense Logistics Agency awarded a $2,777.32 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Mounjaro 7.5 mg/0.5 ml pen injectors on September 8, 2025, with completion targeted for September 9, 2025. This delivery order, issued without a set-aside designation, represents a competitive award under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $8,162.70 for Mounjaro 7.5 mg/0.5 ml pen auto-injectors on July 23, 2025, with completion targeted for July 24, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The order will be fulfilled at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. Mounjaro is a diabetes medication used for glycemic control, representing part of the company's...
- The Defense Logistics Agency awarded a delivery order valued at $9,747.92 to AmerisourceBergen Drug Corp for the supply of Mounjaro 7.5 mg/0.5 ml pen injectables on October 30, 2025, with an ultimate completion date of October 31, 2025. This competitively awarded, firm fixed price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Mounjaro is a prescription medication used in diabetes management, consistent with...
- The Defense Logistics Agency awarded a $6,045.27 delivery order to AmerisourceBergen Drug Corp for Mounjaro 5 mg/0.5 ml pen injections on August 13, 2025, with completion targeted for August 14, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Mounjaro is a diabetes medication, consistent with AmerisourceBergen's established portfolio of...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,767.23 to AmerisourceBergen Drug Corp for the supply of Mounjaro 7.5 mg/0.5 mL pens on November 13, 2025, with an ultimate completion date of November 14, 2025. This is a firm fixed price delivery order with no set-aside designation, issued under a competitive procurement process. The product will be delivered to the company's location in Conshohocken, Pennsylvania. Mounjaro is a diabetes medication, consistent with...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $45,099.00 for Mounjaro 5 mg/0.5 mL pen injections on September 9, 2025, with completion scheduled for September 10, 2025. This competitively awarded, firm fixed-price delivery order was issued without set-aside designation and will be performed at the awardee's corporate office in Conshohocken, Pennsylvania. Mounjaro is a diabetes medication used for glycemic control, consistent with...
- The Defense Logistics Agency awarded a delivery order valued at $3,057.94 to AmerisourceBergen Drug Corp for Mounjaro 7.5 mg/0.5 ml pen injectors on September 3, 2025, with completion scheduled for September 4, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Mounjaro is a diabetes treatment medication, consistent with AmerisourceBergen's extensive...
- The Defense Logistics Agency awarded a delivery order valued at $10,883.60 to AmerisourceBergen Drug Corp for the supply of Mounjaro 7.5 mg/0.5 mL pen injectors on September 24, 2025, with completion targeted for September 25, 2025. This is a firm fixed price, non-set-aside contract with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a $2,468.75 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Mounjaro 7.5 mg/0.5 ml pen injections on August 12, 2025, with an ultimate completion date of August 13, 2025. This is an unset-aside, competitively awarded contract with performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $6,162.70 for Mounjaro 5 mg/0.5 mL pen injectors on August 20, 2025, with completion expected by August 21, 2025. This firm fixed-price delivery order was competitively awarded without set-aside provisions and will be performed at the vendor's corporate headquarters in Conshohocken, Pennsylvania. Mounjaro is a diabetes medication used for glycemic control in patients with type 2 diabetes. This delivery...
- SPE2DB24D3013Indefinite Delivery Contract
- SPE2DB24D3013-SPE2DB26FFGHZDelivery Order
The Defense Logistics Agency awarded a $25,456.08 delivery order to AmerisourceBergen Drug Corp for Mounjaro 7.5 mg/0.5 ml pen injections on November 12, 2025, with completion targeted for November 13, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Mounjaro is a diabetes medication used for glycemic control, consistent with AmerisourceBergen's extensive portfolio of pharmaceutical products supplied to federal healthcare systems. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion prime contract vehicle running through December 2026 that enables the company to supply pharmaceutical products and medical supplies supporting military healthcare programs globally. AmerisourceBergen, as a major pharmaceutical distributor headquartered in Pennsylvania, serves critical federal medical procurement needs for defense and veteran healthcare systems through competitively awarded contracts covering diverse therapeutic domains including specialty medications, vaccines, and medical devices. The contract reflects DLA's ongoing pharmaceutical supply chain requirements across military medical facilities and healthcare beneficiaries worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $25.5k | 11/12/25 |